The synthesis of 2-iodo-1-methylimidazole (4) and 1-methyl-2-trimethylsilyethynylimidazole (5) were performed following literature procedures. [8][9][10] NMR spectra were recorded on a Bruker DPX 300 AVANCE, δ are given values relative to the residual solvent signal (1H: CHCl3, 7.26 ppm;
Experimental Section
The synthesis of 2-iodo-1-methylimidazole (4) and 1-methyl-2-trimethylsilyethynylimidazole (5) were performed following literature procedures. [8] [9] [10] NMR spectra were recorded on a Bruker DPX 300 AVANCE, δ are given values relative to the residual solvent signal (1H: CHCl3, 7.26 ppm; 13 C{ 1 H}: CDCl3, 77.2 ppm). Elemental analyses were carried out on a Euro EA 3000 (Euro Vector). Infrared spectra were recorded with a EXCALIBUR FTS-3500 FT-IR spectrometer. X-Ray structure analyses were carried out on a Bruker Kappa CCD (SADABS-2008 /1 (Bruker, 2008 ). All calculations were carried out with the SHELX97 software package.
2-(2-Chloroethenyl)-N-methylimidazole-2-yl (3a,b):
To a solution of (chloromethyl)triphenylphosphonium chloride (25.0 g, 72.0 mmol) in THF (100 mL) n-butyllithium (45.0 mL, 72.0 mmol, 1.60 ᴍ in hexanes) was added drop wise at 0 °C, and stirred for 1 h. Subsequently 1-methylimidazole-2-carbaldehyde (2) (5.00 g, 45.0 mmol) was added and stirred for 12 hours at room temperature. The yellow-brown product containing a mixture of E/Z-isomers was purified by column chromatography (silica, 6 × 20 cm, hexane/EtOAc 5/1 and silica 6 × 40 cm, CHCl3/MeOH 12/1) yielding a brown oil. (1.60 g, 11.2 mmol, 25 %). 
2-Ethynyl-N-methylimidazole-2-yl (6):
Route A -A Schlenk flask was charged with 1-methyl-2-trimethylsilyethynylimidazole (5) (490 mg, 2.75 mmol) and MeOH (25 mL). After the addition of KOH (13.4 M, 2 mL) the reaction mixture was stirred 2 h. The mixture was diluted with water (100 mL), extracted with CHCl3 (4 × 50 mL) and dried over Na2SO4. The solvent was removed by rotary evaporator and the crude product was purified by column chromatography (silica, 4 × 5 cm, EtOAc/hexane 3/1) to give yellow oil (254 mg, 2.39 mmol, 87 %). Characterization see below. Route B -A round bottom flask was charged with 2-(2-chloroethynyl)-N-methylimidazol-2-yl (3a,b) (400 mg, 2.80 mmol) in dried THF (10 mL), and potassium-tert-butoxide (670 mg, 59.0 mmol) in THF (10 mL) was added at 0 °C. The mixture was stirred for 12 hours at room temperature. Afterwards the mixture was poured on ice water and neutralized with a solution of ammonium chloride (20%). The brown mixture was extracted with CH2Cl2 (4 × 50 mL), dried over Na2SO4. The solvent was removed by rotary evaporator. The product was purified by column chromatography (silica 3 × 30cm, CHCl3/MeOH/Et3N, 12/1/1) to yield a yellow-brown oil (90.0 mg 0.80 mmol, 28.5% Bis(N-methylimidazol-2-yl)butadiyne (bmib) (7): CuCl (0.049 g, 0.500 mmol) in pyridine (3 mL) was reacted with 2-ethynyl-N-methylimidazole (6) (0.530 g, 5.00 mmol) under oxygen atmosphere for 1.5 h at 45 °C. Pyridine was removed in vacuum, the brown residue was washed with aqueous NH4Cl solution (10%, 70 mL), and extracted with CH2Cl2 (3 × 100 mL). The combined organic phases were washed (sat. NH4Cl solution), and dried (MgSO4). Solvent was removed and the product was purified by column chromatography (silica, Ø = 3 cm, 30 cm, CHCl3/MeOH/Et3N, _publ_contact_letter ; Please consider this CIF submission (2 compounds) for structural data deposition. We are awaiting a notice about the assigned CSD numbers. ; 
_audit_creation_date 2013-06-28T11:59:27-00:00 _audit_creation_method 'WinGX routine CIF_UPDATE'
? ; _chemical_formula_moiety 'C12 H10 N4' _chemical_formula_sum 'C12 H10 N4' _chemical_formula_weight 210.24 _chemical_compound_source 'synthesis as described' ? ;
150 (2) 
Refinement of F^2^ against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F^2^, conventional R-factors R are based on F, with F set to zero for negative F^2^. 
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. 
2013-06-28T11:26:43-00:00 _audit_creation_method 'WinGX routine CIF_UPDATE'
? ; _chemical_formula_moiety 'C44 H50 N8 O20 Zn5' _chemical_formula_sum 'C44 H50 N8 O20 Zn5' _chemical_formula_weight 1337.87 _chemical_compound_source 'synthesis as described' ? ;
#----------------------------------------------------------------------------# # UNIT CELL INFORMATION # #----------------------------------------------------------------------------
2.344 _exptl_absorpt_correction_type multi-scan _exptl_absorpt_process_details 'SADABS, Bruker-AXS, 2002' _exptl_absorpt_correction_T_min 0.5815 _exptl_absorpt_correction_T_max 0.7454
150 (2) -86 (Sheldrick, 1986 )' _computing_structure_refinement 'SHELXL-97 (Sheldrick, 1997)' _computing_molecular_graphics 'Ortep-3 for Windows (Farrugia, 1997)' _computing_publication_material 'WinGX publication routines (Farrugia, 1999)'
#----------------------------------------------------------------------------# # MOLECULAR GEOMETRY # #----------------------------------------------------------------------------# _geom_special_details ;
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. ; loop_ _geom_bond_atom_site_label_1 _geom_bond_atom_site_label_2 _geom_bond_distance _geom_bond_site_symmetry_2 _geom_bond_publ_flag C1 C2 1.193(7) . ? C1 C11 1.420(7) . ? C2 C3 1.365(8) . ? C3 C4 1.202(7) . ? C4 C21 1.407(7) . ? C11 N11 1.323(6) . ? C11 N12 1.366(6) . ? C12 N12 1.340(7) . ? C12 C13 1.366(7) . ?
